NCCN小细胞肺癌临床指引(2002.1版)
被引量：1
NCCN Small Cell Lung Cancer Practice Guidelines
摘要
1目录
NCCN小细胞肺癌专家组成员(附后)
出处
《循证医学》
CSCD
2003年第1期51-64,共14页
The Journal of Evidence-Based Medicine
基金
广东省科技厅重点科技项目(2KM05801S)
广东省卫生厅"五个一科教兴医工程"重点项目(粤卫科[2000]15号)
参考文献95
-
1[1]Aisner J. Extensive-disease small-cell lung cancer: The thrill of victory the agony of defeat. J Clin Oncol, 1996,14:658 -665
-
2[2]Arriagada R, Kramar A, Le Chevalier T, et al. Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Oncol, 1992,10:447 - 451
-
3[3]Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Nail Cancer Inst, 1995,87: 183 - 190
-
4[4]Arriagada R, Le Chevalier T, Pignon J-P, et al. Initial chemo therapeutic doses and survival in patients with limited small cell lung cancer. N Engl J Med,1993,329:1848-1852
-
5[5]Auperin A, Arriagada R, Pignon J-P, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med, 1999,341: 476 - 484
-
6[6]Bishop J F, Raghavan D, Stuart-Harris R, et al. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small cell lung cancer. J Clin Oncol, 1987,5: 1574- 1578
-
7[7]Brennan J, O'Connor T, Makuch R, et al. Family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res, 1991,51: 1708 - 1712
-
8[8]Brower M, Ihde D C, Johnston-Early A, et al. Treatment of extensive stage small cell bronchogenic carcinoma: Effects of variation in intensity of induction chemotherapy. Am J Med, 1983, 75:993 - 1000
-
9[9]Burbee D G, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSFIA in lung and breast cancers and malignant phenotype suppression. JNCl, 2001, 93:691 - 699
-
10[10]ChoiNC, HerndonⅡJ E, RosenmanJ, et al Phase I study to determine the maximum tolerated dose (MTD) of radiation in standard daily and hyperfractionated accelerated twice daily radiation schedules with concurrent chemotherapy for limited stage small cell lung cancer (Cancer and Leukemia Group B 8837). J Clin Oncol, 1998, 16: 3528- 3536
同被引文献4
-
1Evans WK,Shepherd F A,Feld R,et al.VP-16 and cisplatin as firstiline therapy for small cell lung cancer[J].J Clin Oncol,1985,3:1417-1477.
-
2E Carmack Holmes.Surgical treatment of small cell lung cancer[J].Lung Cancer,1994,11:228.
-
3Pignon JP,Arriagada R,Ihde DC,et al.A meta-analysis of thoracic radiotherapy for small cell lung cancer[J].N EngI J Med,1992,327:1618-1624.
-
4Salzer GM,Muller LC,Huber H,et al. Operation for N2 small cell lung carcinoma[J].Ann Thorac Surg,1990,49:759-762.
二级引证文献6
-
1曹立明,胡成平,杨红忠,苏晓莉,杨华平.98例小细胞肺癌化疗疗效分析[J].肿瘤防治研究,2007,34(10):785-787. 被引量：1
-
2田瑞芬,谢才良.依托泊苷联合顺铂方案治疗小细胞肺癌87例[J].肿瘤研究与临床,2009,21(2):129-131.
-
3吴大广.80例晚期小细胞肺癌的化疗方案探讨[J].医学信息（中旬刊）,2011,24(2):441-442.
-
4范登.100例细胞肺癌化疗疗效观察[J].中国中医药咨讯,2011,3(7):147-148. 被引量：1
-
5魏春勇,汪礼旭,李志华,陈亮.小细胞肺癌手术治疗与化疗疗效的临床研究[J].中国医药科学,2013,3(12):189-190. 被引量：1
-
6李小伟.对晚期小细胞肺癌的化疗方案探讨[J].现代养生,2016,0(8):198-198.
-
1邱红,于世英.NCCN成人癌性疼痛治疗临床指引(2006.1版)[J].循证医学,2006,6(5):304-316. 被引量：19
-
2马冬.NCCN结肠癌临床指引(2005.4版)[J].循证医学,2005,5(6):372-384.
-
3杨学宁(翻译),廖日强(翻译),吴一龙(翻译).NCCN非小细胞肺癌临床指引(2002.1版)[J].循证医学,2002,2(4):243-256. 被引量：10
-
4杨学宁,廖日强,吴一龙,陈刚.NCCN非小细胞肺癌临床指引2004/2005版更新[J].循证医学,2004,4(4):252-256. 被引量：9
-
5吴一龙,张明和,廖美琳,周清华,蒋国樑,支修益,王俊,陈刚,王思愚,杨学宁,孙燕.肺癌的诊断和分期临床指引[J].中国肺癌杂志,2003,6(5):330-334. 被引量：38
-
6韩柳,于世英.NCCN儿童肿瘤疼痛临床指引(2006.1版)[J].循证医学,2007,7(3):175-188. 被引量：5
-
7韩柳,于世英.NCCN老年肿瘤临床指引(2005.1版)[J].循证医学,2006,6(6):364-374. 被引量：4
-
8马冬,杨学宁.NCCN胃癌临床指引(2003.1版)[J].循证医学,2004,4(1):56-64. 被引量：6
-
9邹燕梅,于世英.NCCN止吐临床指引(2005．1版)[J].循证医学,2006,6(1):54-64. 被引量：34
